Division of Research Spotlight
The Kaiser Permanente Division of Research conducts, publishes, and disseminates epidemiologic and health services research to improve the health and medical care of Kaiser Permanente members and society at large. We seek to understand the determinants of illness and well-being, and to improve the quality and cost-effectiveness of health care. Currently, DOR’s 550-plus staff is working on more than 350 epidemiological and health services research projects.
Kaiser Permanente study finds new classification and automated referral system benefits patients.
In this new episode of KP Research Radio, we talk with Brooke Vuong, MD, a breast cancer surgeon at the Kaiser Permanente South Sacramento Medical Center, about her research on the Surgical Home Recovery Program and the impact the program has had on her patients.
Listen to our new KP Research Radio episode and learn more about the risks and benefits of the PSA test to screen for prostate cancer.
New research from Kaiser Permanente that followed a large number of people living with HIV over 15 years finds reduced risk of certain cancers is among the benefits of early treatment.
Early career researcher Marvin Langston, PhD, MPH, studies potential links between infections, inflammation, and cancer as well as racial/ethnic and sexual minority health disparities.
Kaiser Permanente researchers showed starting annual colorectal cancer screening at age 45 in African Americans can find colorectal cancers at a rate similar to that seen when screening starts after age 50 — the age most guidelines currently recommend.
A new prostate cancer risk calculator developed by Kaiser Permanente Northern California researchers may help men going through prostate cancer screening decide whether to have a prostate biopsy.
Research scientist Stephen Van Den Eeden, PhD, is a co-founder of the California Men's Health Study, one of the largest and longest-running cohort studies of men in the world.
Kaiser Permanente researcher receives $4.5 million from the National Cancer Institute to study link between inflammation in the breast’s fatty tissue and breast cancer outcomes.
David Baer, MD, cofounded the KP Oncology Clinical Trials program in the 1980s. He has enrolled significant numbers of patients in these trials, and helped expand the regional effort into a national KP program. As a leading member of the Northern California Central Research Committee for most of his career, he provides valuable experience in the practicality of research within Kaiser Permanente.